Fig. 11From: Pharmacological mechanism and therapeutic efficacy of Icariside II in the treatment of acute ischemic stroke: a systematic review and network pharmacological analysisRMSF of ICS II. Most of the residues had low fluctuation values in other regions, which indicated that the residues are stable in binding to the proteinBack to article page